Omega Genetik
All Episodes

The THUNDER Study: Clinical Evidence for OverC®

25.10.2026 17 min

The evidence speaks: we present the study with honest numbers.

The audio for this episode is coming soon.

This episode may have been prepared with AI assistance; it may contain gaps or phrasing errors. It is for general information only and does not constitute medical advice. For your health decisions, please consult your physician or the Omega Genetik center.

About the Episode

THUNDER is the first prospective, independent, blinded validation study of multi-cancer early detection conducted in China. This episode covers the study design, the 69.1% sensitivity and 98.9% specificity results across six cancer types, the tissue-of-origin prediction accuracy (83.2% / 91.7%), and what these numbers do and do not mean.

The main theme: what high specificity and limited sensitivity imply in a screening context.

#overc #kanıtlar

Rx-only — prescription screening test. Galleri® is not a diagnostic test. A positive result does not mean a cancer diagnosis; a negative result does not rule out cancer. The test does not replace the routine cancer screenings recommended by your physician. Galleri® does not detect all cancers.

Get Information